Transcript

Claire Moulton: The Company of Biologists has a long-standing commitment to innovation in Open Access publishing and we’re delighted that our cost-neutral and uncapped Read & Publish Open Access initiative is continuing to go from strength to strength.

Claire Moulton: Corresponding authors at over 400 institutions across 32 countries now benefit from uncapped APC-free publishing for their research articles. We have signed agreements with library consortia in seven countries – most recently with the Council of Australian University Librarians. We have also signed a landmark agreement with EIFL that offers APC-free OA publishing to authors in 30 developing and transition economy countries.

Claire Moulton: So the question is – have Read & Publish agreements had an impact on Open Access publishing? Absolutely! The success of our Read & Publish initiative has helped us to significantly increase the proportion of research content that is published immediately Open Access.

Claire Moulton: Our hybrid journals were the first from any publisher to be afforded Transformative Journal status, and target Open Access growth for 2021 was 5%. Our actual growth was more than double that.

Claire Moulton: We are also delighted that from this year our two fully Open Access journals can also be included in our Read & Publish agreements.

Claire Moulton: We look forward to continuing to work closely with our library partners and the wider research community to accelerate a sustainable transition to Open Access.